Can triamcinolone acetonide be used for yeast infection

Effects of triamcinolone acetonide on experimental oral candidiasis in monkeys

E Budtz-Jörgensen. Scand J Dent Res. 1975 May.

Abstract

Thirteen adult monkeys (Macaca irus) were infected with Candida albicans by inoculating the microorganisms under an acrylic plate covering the palatal mucosa. Six of the monkeys were treated with the steroid triamcinolone acetonide intramuscularly for 2 weeks before and 2 weeks after inoculation. The palatal mucosa was studied clinically and histologically at weekly or biweekly intervals for up to 5 months after inoculation. The cellular immune response was studied using the direct leukocyte migration test. In the group of seven non-steriod-treated monkeys an acute atrophic candidiasis developed that healed spontaneously in 2-3 weeks. No tissue invasion by Candida was seen in tissue sections, but the inflammation was pronounced. Migration inhibition was significant up to 5 months after infection. In the group of six steroid-treated monkeys an acute pseudomembranous candidiasis was induced that showed retarded healing, tissue invasion by Candida, and enhanced yeast proliferation. Inflammation was only slight and the peripheral blood leukocytes were not inhibited in their migration by Candida antigen. The study has shown that systemic treatment with the steroid, triamcinolone acetonide, potentiate oral Candida infections, probably by suppressing both non-specific inflammatory responses and cellular immunity.

Similar articles

• Immune response to C. albicans in monkeys with experimental candidiasis in the palate.

  Budtz-Jörgensen E. Budtz-Jörgensen E. Scand J Dent Res. 1973;81(5):360-71. doi: 10.1111/j.1600-0722.1973.tb00339.x. Scand J Dent Res. 1973. PMID: 4202793 No abstract available.

• Nystatin-resistance of candida albicans isolates from two cases of oral candidiasis.

  Martin MV, Dinsdale RC. Martin MV, et al. Br J Oral Surg. 1982 Dec;20(4):294-8. doi: 10.1016/s0007-117x(82)80026-7. Br J Oral Surg. 1982. PMID: 6760890

• Incidence of oral candidiasis during therapy with triamcinolone acetonide aerosol.

  Chervinsky P, Petraco AJ. Chervinsky P, et al. Ann Allergy. 1979 Aug;43(2):80-3. Ann Allergy. 1979. PMID: 380416 Clinical Trial.

• Oral Candida: clearance, colonization, or candidiasis?

  Cannon RD, Holmes AR, Mason AB, Monk BC. Cannon RD, et al. J Dent Res. 1995 May;74(5):1152-61. doi: 10.1177/00220345950740050301. J Dent Res. 1995. PMID: 7790592 Review.

• Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis.

  Jeal W, Faulds D. Jeal W, et al. Drugs. 1997 Feb;53(2):257-80. doi: 10.2165/00003495-199753020-00006. Drugs. 1997. PMID: 9028745 Review.

Cited by

• Experimental oral candidiasis in animal models.

  Samaranayake YH, Samaranayake LP. Samaranayake YH, et al. Clin Microbiol Rev. 2001 Apr;14(2):398-429. doi: 10.1128/CMR.14.2.398-429.2001. Clin Microbiol Rev. 2001. PMID: 11292645 Free PMC article. Review.

MeSH terms

Substances

Objective: To determine the effectiveness of triamcinolone cream in the treatment of non-specific pruritus vulvae.

Methods: A total of 50 patients, aged between 8 and 55 years, with non-specific pruritus vulvae were consecutively included in a double-blind randomized controlled trial by their general practitioner in 25 general practices in the Netherlands. Analysis was by "intention to treat". An infectious cause was excluded by a vaginal and cervical swab. After randomization, 27 patients were treated with triamcinolone cream and 23 patients with a placebo cream. The effectiveness was assessed by: change in the severity of itch visual analogue scale (VAS) score; the percentage of patients with complete recovery; and changes in general health according to COOP/WONCA charts.

Results: The mean decrease in severity of itch was 2.08 points in the triamcinolone group compared to 3.26 points in the placebo group. Forty-two per cent of the women in the triamcinolone group completely recovered versus 35% in the placebo group. There was no difference in general health perception between the two groups. After 12 weeks, more than 80% in both groups reported recurrent vulval itch.

Conclusion: No significant differences in effectiveness were found between the two groups, because both treatments were ineffective. We can conclude that triamcinolone cream is therefore not the treatment of first choice for non-specific pruritus vulvae.

Can you put triamcinolone on private area?

Does triamcinolone acetonide stop yeast infection itching?

Can triamcinolone acetonide be used for Candida?

How do you use Nystatin and triamcinolone acetonide cream for yeast infection?